Address: DM Plaza, 24th Floor, Suite 2401 Jl. Jend. Sudirman Kav. 25 Jakarta 12920,Indonesia
Tel: +62 21 2557 9700
Web: http://www.quintiles.com/locations/asia/indonesia/
Quintiles Indonesia has been in operation since 2006, providing expert clinical services and innovative commercial solutions for our customers. Our office offers experienced local staff, adherence to Quintiles’ global quality standards and our understanding of the local environment, which has allowed us to delight our BioPharmaceutical customers.
Key Services in Indonesia to Support Your Clinical Trials
• Clinical Monitoring
• Patient Recruitment
• Site Management
Access through Our Indonesia Team to Quintiles Worldwide
• Access to Patients Services
• Biostatistics
• Central Labs
• Data management
• Drug safety/pharmacovigilance
• ECG services
• Project Management
• Regulatory specialists
• Consulting Services
• Partnering
What role does Indonesia play within Quintiles’ Asian operations? Quintiles has been growing dramatically across the South East Asian Region, which comprises Philippines, Singapore, Thailand, Malaysia, Vietnam and Indonesia as…
Rahardjo Jamtomo is the executive director of Kadin Indonesia, the Indonesian Chamber of Commerce and Industry that has seen its role increasing in recent years. As the Chamber has been…
Dr. Agus Prabowo, chairman at LKPP (the Indonesian National Public Procurement Agency) explains the importance of embracing technology to gain efficiency and effectiveness in the public procurement process of healthcare…
Dr. Hasbullah Thabrany, chairman at the Center for Social Security Studies Universitas Indonesia (CSSUI) and Senior Health Care Financing Consultant to the National Social Security Council of Indonesia, explains the…
Dr. Sigit Priohutomo, chairman of DJSN (National Social Security Council of Indonesia), explains DJSN’s action plan to implement the SJSN (Indonesian Social Security System), meant to offer basic social security…
Alban Nérot, managing director at Servier Indonesia, explains the transformational change of the Indonesian affiliate to ensure the sustainable growth of its business in the country as well as the…
Chris Wren, Executive Director of BritCham for the last ten years, explains the changes that have happened on the Indonesian market as well as opportunities for foreign companies to invest…
Parulian Simanjuntak, Executive Director at IPMG, explains the crucial role that MNCs should play within Indonesian universal healthcare coverage (JKN) and discusses the future challenges that should be addressed to…
Steve Yang, Chief Executive Officer of Metiska Farma, talks about the changes he implemented to the comopany once he took over for his father in 2009 and what it means…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote medical communities, and why changing the mindset from ‘guinea…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote medical communities, and why changing the mindset from ‘guinea…
The CEO of independent distributor Anugerah Pharmindo Lestari (APL) discusses the current market trends in Indonesia for distribution, which involve local pharma companies keeping their distribution in-house, and how his company,…
The CEO of Metiska Farma talks about coming back to Indonesia after studying in the US at Berkeley and MIT, to take over the company, and the company’s strategy of…
See our Cookie Privacy Policy Here
